KDA Group Inc. announced the appointments of Mr. Sylvain Duvernay as Chief Executive Officer and Mr. Pierre Monet as Chief Financial Officer of the Corporation, effective immediately. Sylvain Duvernay has over 20 years of experience in pharmaceutical and international business. Mr. Duvernay filled the position of Vice-President for Strides Arcolab Ltd. a pharmaceutical generic product company involved in softgel, injectable and solid dose manufacturing. He ed its Canadian operations as well as its business development in the United States. Mr. Monet has more than 35 years' experience in public and private companies at national and international levels. He has a solid background in finance combined with operations management. He has played key roles in mergers and acquisitions as well as corporate restructuring. He has a strategic and results-oriented mind. The Corporation's current Chief Executive Officer, Mr. Marc Lemieux, will remain Chairman of the Board and Director, while the current Chief Financial Officer, Mrs. Annie Mercier, will now assume the role of Controller of KDA. The Board of Directors would like to thank Mr. Lemieux and Mrs. Mercier for all their loyal service over the years and good continuation within the Corporation.